Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 6119-6127

  Gao, Zhiguang ^a   Guo, Bomin ^a   Gao, Renyuan ^a   Zhu, Qingchao ^a   Wu, Wen ^a   Qin, Huanlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Colorectal cancer; Dysbiosis; Fusobacterium; Mucosa associated microbiota; Probiotics

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN; PROBIOTIC AGENT; RNA 16S; BACTERIAL DNA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCENDING COLON; BIFIDOBACTERIUM LONGUM; BODY MASS; CANCER PATIENT; CANCER PREVENTION; CANCER STAGING; COLONY FORMING UNIT; COLORECTAL CANCER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DESCENDING COLON; DIET SUPPLEMENTATION; ENTEROCOCCUS FAECALIS; FEMALE; FUSOBACTERIUM; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; MALE; MICROFLORA; POPULATION BASED CASE CONTROL STUDY; PYROSEQUENCING; RANDOMIZED CONTROLLED TRIAL; RECTUM; SIGMOID; COLORECTAL NEOPLASMS; DNA SEQUENCE; GENETICS; MICROBIOLOGY; MIDDLE AGED;

ADULT; AGED; BODY MASS INDEX; COLORECTAL NEOPLASMS; DNA, BACTERIAL; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROBIOTICS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84940553504     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4124     Document Type: Article

References (49)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Li D, Wu C, Zheng Y, Zhong W and Wu F: Incidence and mortality of colorectal cancer in Shanghai from 2003 to 2007. Zhongguo Zhongliu 20: 413-418, 2011.
3. Woolf CM: A genetic study of carcinoma of the large intestine. Am J Hum Genet 10:42-47, 1958.
4. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, Bond JH, Waye JD, Schapiro M and Panish JF: Risk of colorectal cancer in the families of patients with adenomatous polyps National Polyp Study Workgroup. N Engl J Med 334: 82-87, 1996.
5. Magrone T and Jirillo E: The interaction between gut microbiota and age-related changes in immune function and infammation. Immun Ageing 10: 31, 2013.
6. O'Toole PW: Changes in the intestinal microbiota from adulthood through to old age. Clin Microbiol Infect 18: 44-46, 2012.
7. DiBaise JK, Frank DN and Mathur R: Impact of the gut microbiota on the development of obesity: Current concepts. Am J Gastroenterol 1 (Suppl): 22-27, 2012.
8. Kallus SJ and Brandt LJ: The intestinal microbiota and obesity. J Clin Gastroenterol 46: 16-24, 2012.
9. Rubinstein MR, Wang X, Liu W, Hao Y, Cai GF and Han YW: Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating e-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14: 195-206, 2013.
10. Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault M, Van Nhieu JT and Delchier JC: Microbial dysbiosis and colon carci-nogenesis: could colon cancer be considered a bacteria-related disease?. Therap Adv Gastroenterol 6: 215-229, 2013.
11. Tjalsma H, Boleij A, Marchesi JR and Dutilh BE: A bacterial driver-passenger model for colorectal cancer: Beyond the usual suspects. Nat Rev Microbiol 10: 575-582, 2012.
12. Ley RE, Peterson DA and Gordon JI: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848, 2006.
13. Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, Ojetti V, Scarpellini E and Gasbarrini A: The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci 17: 323-333, 2013.
14. Xu X, Xu P, Ma C, Tang J and Zhang X: Gut microbiota, host health and polysaccharides. Biotechnol Adv 31: 318-337, 2013.
15. Compare D and Nardone G: The bacteria-hypothesis of colorectal cancer: Pathogenetic and therapeutic implications. Transl Gastrointest Cancer 3: 44-53, 2014.
16. Rowland I: Probiotics and colorectal cancer risk. Br J Nutr 91: 805-807, 2004.
17. Uccello M, Malaguarnera G, Basile F, D'agata V, Malaguarnera M, Bertino G, Vacante M, Drago F and Biondi A: Potential role of probiotics on colorectal cancer prevention. BMC Surg 12: S35, 2012.
18. Delia P, Sansotta G, Donato V, Frosina P, Messina G, De Renzis C and Famularo G: Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 13: 912-915, 2007.
19. Famularo G, Mosca L, Minisola G, Trinchieri V and De Simone C: Probiotic lactobacilli: A new perspective for the treatment of infammatory bowel disease. Curr Pharm Des 9: 1973-1980, 2003.
20. Ljungh A and Wadström T: Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol 7: 73-89, 2006.
21. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, et al: Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium diffcile diarrhoea in older inpatients (PLACIDE): A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 382: 1249-1257, 2013.
22. Mackowiak PA: Recycling metchnikoff: Probiotics, the intestinal microbiome and the quest for long life. Front Public Health 1: 52, 2013.
23. Allen SJ, Martinez EG, Gregorio GV and Dans LF: Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 10: CD003048, 2010.
24. Chen CC, Kong MS, Lai MW, Chao HC, Chang KW, Chen SY, Huang YC, Chiu CH, Li WC, Lin PY, et al: Probiotics have clinical, microbiologic and immunologic efficacy in acute infectious diarrhea. Pediatr Infect Dis J 29: 135-138, 2010.
25. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B and Shekelle PG: Probiotics for the prevention and treatment of antibiotic-associated diarrhea a systematic review and meta-analysis. JAMA 307: 1959-1969, 2012.
26. Koebnick C, Wagner I, Leitzmann P, Stern U and Zunft HJ: Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 17: 655-659, 2003.
27. Ouwehand AC, Lagström H, Suomalainen T and Salminen S: Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 46: 159-162, 2002.
28. de Milliano I, Tabbers MM, van der Post JA and Benninga MA: Is a multispecies probiotic mixture effective in constipation during pregnancy? 'A pilot study'. Nutr J 11: 80, 2012.
29. Persborn M and Söderholm JD: Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis-authors' reply. Aliment Pharmacol Ther 38: 1406-1407, 2013.
30. Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, Forti G, Morini S, Hassan C, Pistoia MA, et al: Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic Vs.L#3 as adjunctive to a standard pharmaceutical treatment: A double-blind, randomized, placebo-controlled study. Am J Gastroenterol 105: 2218-2227, 2010.
31. Müllner K, Miheller P, Herszényi L and Tulassay Z: Probiotics in the management of Crohn's disease and ulcerative colitis. Curr Pharm Des 20: 4556-4560, 2014.
32. Huebner C, Ding Y, Petermann I, Knapp C and Ferguson LR: The probiotic Escherichia coli Nissle 1917 reduces pathogen invasion and modulates cytokine expression in Caco-2 cells infected with Crohn's disease-associated E. coli LF82. Appl Environ Microbiol 77: 2541-2544, 2011.
33. Kõljalg U, Nilsson RH, Abarenkov K, Tedersoo L, Taylor A F, Bahram M, Bates ST, Bruns TD, Bengtsson-Palme J, Callaghan TM, et al: Towards a unifed paradigm for sequence-based Identification of fungi. Mol Ecol 22: 5271-5277, 2013.
34. Hamady M, Walker JJ, Harris JK, Gold NJ and Knight R: Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 5: 235-237, 2008.
35. Edgar RC: UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10: 996-998, 2013.
36. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J and Glöckner FO: The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res 41: D590-D596, 2013.
37. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P and Andersen GL: Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72: 5069-5072, 2006.
38. Appleyard CB, Cruz ML, Isidro AA, Arthur JC, Jobin C and De Simone C: Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol 301: G1004-G1013, 2011.
39. Fotiadis CI, Stoidis CN, Spyropoulos BG and Zografos ED: Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World J Gastroenterol 14: 6453-6457, 2008.
40. Wollowski I, Rechkemmer G and Pool-Zobel BL: Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73: 451S-455S, 2001.
41. Bertkova I, Hijova E, Chmelarova A, Mojzisova G, Petrasova D, Strojny L, Bomba A and Zitnan R: The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats. Neoplasma 57: 422-428, 2010.
42. Vipperla K and O'Keefe SJ: The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr Clin Pract 27: 624-635, 2012.
43. Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, van-Hylckama Vlieg JE, Strissel K, Zhao L, Obin M and Shen J: Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME 9: 1-15, 2015.
44. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et al: Genomic analysis identifes association of Fusobacterium with colorectal carcinoma. Genome Res 22: 292-298, 2012.
45. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S and Zhao L: Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6: 320-329, 2012.
46. Allen-Vercoe E, Strauss J and Chadee K: Fusobacterium nucleatum: An emerging gut pathogen? Gut Microbes 2: 294-298, 2011.
47. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, Lynch T and Allen-Vercoe E: Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Infamm Bowel Dis 17: 1971-1978, 2011.
48. Arthur JC and Jobin C: The struggle within: Microbial Influences on colorectal cancer. Infamm Bowel Dis 17: 396-409, 2011.
49. Chaikham P and Apichartsrangkoon A: Effects of encapsulated Lactobacillus acidophilus along with pasteurized longan juice on the colon microbiota residing in a dynamic simulator of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol 98: 485-495, 2014.